BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call

AI Briefing

• – BioVersys AG reports Q4 2025 financial results and business update, to host conference call.
• – BioVersys AG is a multi-asset, clinical stage biopharmaceutical company focused on antibacterial products for MDR bacteria.
• – Company to discuss financial results and business strategy on conference call.